Yellow Cake (LON:YCA - Get Free Report)'s stock had its "buy" rating reaffirmed by equities researchers at Berenberg Bank in a research report issued on Thursday, Marketbeat Ratings reports. They presently have a GBX 682 ($9.11) price objective on the stock. Berenberg Bank's price objective suggests a potential upside of 36.78% from the stock's current price.
Separately, Royal Bank Of Canada reissued an "outperform" rating and issued a GBX 620 ($8.28) price target on shares of Yellow Cake in a report on Thursday, July 24th.
Read Our Latest Report on YCA
Yellow Cake Price Performance
LON YCA traded up GBX 4.40 ($0.06) during trading on Thursday, hitting GBX 498.60 ($6.66). The company's stock had a trading volume of 665,673 shares, compared to its average volume of 1,377,308. The company has a market cap of £1.08 billion, a PE ratio of 1.87 and a beta of 0.27. The business's 50 day simple moving average is GBX 500.28 and its 200-day simple moving average is GBX 469.36. Yellow Cake has a fifty-two week low of GBX 359 ($4.80) and a fifty-two week high of GBX 622.79 ($8.32).
Yellow Cake Company Profile
(
Get Free Report)
Yellow Cake plc operates in the uranium sector. It is involved in the purchase and holding of uranium oxide concentrates, and exploitation of other uranium-related opportunities. Yellow Cake plc was incorporated in 2018 and is headquartered in Saint Helier, Jersey.
Further Reading
Before you consider Yellow Cake, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Yellow Cake wasn't on the list.
While Yellow Cake currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.